Oculopharyngeal muscular dystrophy as a paradigm for muscle aging
Symptoms in late-onset neuromuscular disorders initiate only from midlife onwards and progress with age. These disorders are primarily determined by identified hereditable mutations, but their late-onset symptom manifestation is not fully understood. Here, we review recent research developments on t...
Main Authors: | Yotam eRaz, Vered eRaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00317/full |
Similar Items
-
PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions
by: Louis-Philippe Corbeil-Girard, et al.
Published: (2005-04-01) -
BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy
by: Vanessa Strings-Ufombah, et al.
Published: (2021-06-01) -
Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy
by: Vered Raz, et al.
Published: (2020-08-01) -
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2019-10-01) -
Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy
by: Ami Mankodi, et al.
Published: (2012-01-01)